HERTI 440MG INJ
Prescription Required
Sale price
₹ 8,300.00
Regular price
MRP: ₹ 55,210.00
85% OFF
Inclusive of all taxes.
Couldn't load pickup availability
HERTI 440MG INJ
Regular price
₹ 8,300.00
Regular price
₹ 55,210.00
Sale price
₹ 8,300.00
(-85%)
Unit price
per
HERTI 440MG INJ
Sale price
₹ 8,300.00
Regular price
MRP: ₹ 55,210.00
85% OFF
- Introduction
- Uses
- Storage
- Safety
- Side effects
- Abouts RareMeds
- Disclaimer
Introduction
Herti 440mg Injection contains trastuzumab, a monoclonal antibody that targets HER2 receptors to slow the growth of HER2-positive cancer cells.
Uses
- Store refrigerated at 2°C–8°C.
- Do not freeze.
- Protect from light in the original carton.
Storage
- Cardiac function should be evaluated before and during treatment.
- Infusion should be administered by trained healthcare professionals.
Safety Information
Possible side effects may include:
- Infusion reactions
- Fever
- Chills
- Nausea
- Fatigue
- Diarrhoea
- Reduced heart function
- Allergic reactions
Possible Side Effects
Herti is a prescription biological anticancer medicine.
It should only be administered under the supervision of a qualified oncologist.
About RareMeds
We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.
The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.
No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.
Disclaimer
Herti is a prescription biological anticancer medicine and should only be administered under the supervision of a qualified oncologist.